Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Calcium430 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A17108 | 27988847 | Eur J Nutr | Calcium and vitamin D3 combinations improve fatty liver disease through AMPK-independent mechanisms. | 2016 | Details |
A17210 | 27913210 | Free Radic Biol Med | TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity. | 2016 | Details |
A17231 | 27898698 | PLoS One | Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr-/- Mice. | 2016 | Details |
A17318 | 27851786 | PLoS One | Calcium Reduces Liver Injury in Mice on a High-Fat Diet: Alterations in Microbial and Bile Acid Profiles. | 2016 | Details |
A17557 | 27749006 | Mol Nutr Food Res | An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high-fat "Western-type" diet in mice. | 2016 | Details |
A17608 | 27720403 | Clin Nutr | Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial. | 2016 | Details |
A17636 | 27697419 | Dig Liver Dis | Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysis. | 2016 | Details |
A17782 | 27599521 | Gut | Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study. | 2016 | Details |
A17879 | 27506731 | Metabolism | Endoplasmic reticulum stress in obesity and obesity-related disorders: An expanded view. | 2016 | Details |
A17897 | 27492505 | Hepatol Res | Emodin alleviates hepatic steatosis by inhibiting sterol regulatory element binding protein 1 activity by way of the calcium/calmodulin-dependent kinase kinase-AMP-activated protein kinase-mechanistic target of rapamycin-p70 ribosomal S6 kinase signaling pathway. | 2016 | Details |
A17944 | 27459811 | Wei Sheng Yan Jiu | [Change in plasma nesfatin-1 concentration within high-fat diet induced nonalcoholic fatty liver disease rat models]. | 2016 | Details |
A18210 | 27284686 | PLoS One | Vitamin D Levels Are Inversely Associated with Liver Fat Content and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Middle-Aged and Elderly Population: The Shanghai Changfeng Study. | 2016 | Details |
A18295 | 27234712 | Mol Nutr Food Res | β-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes. | 2016 | Details |
A18330 | 27206950 | J Clin Lipidol | Relationship of epicardial fat thickness and nonalcoholic fatty liver disease to coronary artery calcification: From the CAESAR study. | 2016 | Details |
A18500 | 27089408 | J Pediatr Endocrinol Metab | Low 25-hydroxyvitamin D level is not an independent risk factor for hepatosteatosis in obese children. | 2016 | Details |
A18643 | 27018279 | Geriatr Gerontol Int | Involvement of senescence marker protein-30 in glucose metabolism disorder and non-alcoholic fatty liver disease. | 2016 | Details |
A18695 | 26997000 | Clin Cardiol | Fatty Liver, Insulin Resistance, and Obesity: Relationships With Increase in Coronary Artery Calcium Over Time. | 2016 | Details |
A18707 | 26989059 | Obes Surg | Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency. | 2016 | Details |
A18806 | 26929777 | Therap Adv Gastroenterol | Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial. | 2016 | Details |
A18808 | 26927097 | Int J Mol Sci | Low Serum Lysosomal Acid Lipase Activity Correlates with Advanced Liver Disease. | 2016 | Details |
A18816 | 26923972 | Clin Calcium | [Non-alcoholic fatty liver disease (NAFLD) /non-alcoholic steatohepatitis (NASH) and nutrition]. | 2016 | Details |
A18910 | 26873633 | Biochim Biophys Acta | iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling. | 2016 | Details |
A18965 | 26845607 | Ann Hepatol |  Monozygotic twins with NASH cirrhosis: cumulative effect of multiple single nucleotide polymorphisms? | 2017 | Details |
A19010 | 26820400 | Clin Gastroenterol Hepatol | Association of Nonalcoholic Fatty Liver Disease With Visceral Adiposity but Not Coronary Artery Calcification in the Elderly. | 2016 | Details |
A19032 | 26811103 | Exp Biol Med (Maywood) | Women may respond different from men to vitamin D supplementation regarding cardiometabolic biomarkers. | 2016 | Details |
A19054 | 26797718 | Obes Surg | Nutritional Status Prior to Laparoscopic Sleeve Gastrectomy Surgery. | 2016 | Details |
A19084 | 26774456 | Biochem Pharmacol | Coral calcium hydride prevents hepatic steatosis in high fat diet-induced obese rats: A potent mitochondrial nutrient and phase II enzyme inducer. | 2016 | Details |
A19147 | 26728181 | J Neuroinflammation | Non-alcoholic fatty liver disease induces signs of Alzheimer's disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model. | 2016 | Details |
A19267 | 26666731 | J Ethnopharmacol | The hepatoprotective effect of the combination use of Fructus Schisandrae with statin--A preclinical evaluation. | 2015 | Details |
A19291 | 26646450 | Oncotarget | Activation of an endothelial Notch1-Jagged1 circuit induces VCAM1 expression, an effect amplified by interleukin-1β. | 2015 | Details |
A19535 | 26503865 | Clin Calcium | [Bone complications in chronic liver disease(hepatic osteodystrophy)]. | 2015 | Details |
A19769 | 26363221 | Mol Cell Endocrinol | AMPK-dependent modulation of hepatic lipid metabolism by nesfatin-1. | 2015 | Details |
A19809 | 26337107 | Curr Med Chem | Emerging Vascular Risk Factors in Women: Any Differences from Men? | 2015 | Details |
A19838 | 26315841 | Int J Obes (Lond) | Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPK. | 2015 | Details |
A19891 | 26281317 | Turk J Med Sci | Effect of pioglitazone, quercetin, and hydroxy citric acid on vascular endothelial growth factor messenger RNA (VEGF mRNA) expression in experimentally induced nonalcoholic steatohepatitis (NASH). | 2015 | Details |
A19954 | 26242295 | Trials | The link between obesity and vitamin D in bariatric patients with omega-loop gastric bypass surgery - a vitamin D supplementation trial to compare the efficacy of postoperative cholecalciferol loading (LOAD): study protocol for a randomized controlled trial. | 2015 | Details |
A20082 | 26169265 | Cardiovasc Diabetol | Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study. | 2015 | Details |
A20089 | 26167086 | World J Gastroenterol | Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome. | 2015 | Details |
A20100 | 26155043 | J Clin Exp Hepatol | The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis. | 2015 | Details |
A20169 | 26113985 | Open Heart | Capsaicin may have important potential for promoting vascular and metabolic health. | 2015 | Details |
A20447 | 25957914 | Int J Biochem Cell Biol | Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway. | 2015 | Details |
A20533 | 25906659 | Lik Sprava | [Optimization of long-term treatment with rosuvastatin of patients with myocardial infarction in combination with non-alcoholic steatohepatitis]. | 2015 | Details |
A20634 | 25844093 | Diabetol Metab Syndr | Nonalcoholic fatty liver disease is associated with coronary artery calcium score in diabetes patients with higher HbA1c. | 2015 | Details |
A20719 | 25776891 | J Hepatol | Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study. | 2015 | Details |
A20857 | 25683387 | Atherosclerosis | The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). | 2015 | Details |
A20868 | 25677815 | Digestion | Association between serum osteocalcin levels and non-alcoholic fatty liver disease in women. | 2015 | Details |
A21081 | 25544877 | World J Hepatol | Vitamin D deficiency in chronic liver disease. | 2014 | Details |
A21113 | 25532375 | Zhongguo Zhong Yao Za Zhi | [Clinical characteristics and combined use of medicine analysis of 2 991 hospitalized patients with psoriasis based on real world database]. | 2014 | Details |
A21123 | 25528845 | Lik Sprava | [Negative effects of termination statinotherapy in patients after acute coronary event with concominent non-alcoholic steatohepatitis]. | 2014 | Details |
A21124 | 25528832 | Lik Sprava | [CORRECTION OF BILE FLOW CHARACTERISTICS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN COMBINATION WITH HYPERURICEMIA]. | 2014 | Details |
A21156 | 25514555 | J Hepatol | Mirtoselect, an anthocyanin-rich bilberry extract, attenuates non-alcoholic steatohepatitis and associated fibrosis in ApoE(∗)3Leiden mice. | 2014 | Details |
A21192 | 25489444 | Int J Prev Med | Effect of Vitamin D Supplementation on C-reactive Protein in Patients with Nonalcoholic Fatty Liver. | 2014 | Details |
A21197 | 25484079 | Autophagy | Calcium channel blockers as potential therapeutics for obesity-associated autophagy defects and fatty liver pathologies. | 2014 | Details |
A21300 | 25422863 | Biochem J | Steatosis inhibits liver cell store-operated Ca²⁺ entry and reduces ER Ca²⁺ through a protein kinase C-dependent mechanism. | 2015 | Details |
A21372 | 25369449 | Radiology | High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial. | 2014 | Details |
A21399 | 25349437 | Proc Natl Acad Sci U S A | DLK1/PREF1 regulates nutrient metabolism and protects from steatosis. | 2014 | Details |
A21436 | 25318838 | J Gastroenterol Hepatol | Association between serum calcium and phosphorus concentrations with non-alcoholic fatty liver disease in Korean population. | 2015 | Details |
A21487 | 25282656 | J Nutr Biochem | Protein carbonylation associated to high-fat, high-sucrose diet and its metabolic effects. | 2014 | Details |
A21658 | 25144390 | Nat Commun | High susceptibility to fatty liver disease in two-pore channel 2-deficient mice. | 2014 | Details |
A21766 | 25061559 | Mol Metab | ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload. | 2014 | Details |
A21932 | 24956534 | Atherosclerosis | Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study. | 2014 | Details |
A22010 | 24893617 | J Diabetes | Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2:. | 2014 | Details |
A22029 | 24867776 | Biol Trace Elem Res | Effect of oleic acid on the levels of eight metal ions in human hepatoma SMMC-7721 cells. | 2014 | Details |
A22050 | 24850606 | Georgian Med News | [Optimization of long-term hypolipidemia treatment of patients with myocardial infarction in combination with non-alcoholic steatohepatitis]. | 2014 | Details |
A22115 | 24806753 | Hepatology | FAM3A activates PI3K p110α/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis. | 2014 | Details |
A22116 | 24805248 | Curr Vasc Pharmacol | Effect of rosuvastatin on non-alcoholic steatohepatitis in patients with metabolic syndrome and hypercholesterolaemia: a preliminary report. | 2014 | Details |
A22147 | 24788803 | Drug Saf | Benefit-risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases. | 2014 | Details |
A22250 | 24719358 | FASEB J | Plasma membrane phospholipase A2 controls hepatocellular fatty acid uptake and is responsive to pharmacological modulation: implications for nonalcoholic steatohepatitis. | 2014 | Details |
A22349 | 24647335 | J Pediatr Gastroenterol Nutr | Role of vitamin D in children with hepatosteatosis. | 2014 | Details |
A22379 | 24630174 | Cell Calcium | Calcium-dependent regulation of glucose homeostasis in the liver. | 2014 | Details |
A22716 | 24361070 | Nutr Metab Cardiovasc Dis | Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis. | 2013 | Details |
A22797 | 24298105 | Clin Med (Lond) | Low vitamin D levels are associated with increased risk for fatty liver disease among non-obese adults. | 2013 | Details |
A22822 | 24284796 | Am J Physiol Cell Physiol | Enhanced endoplasmic reticulum SERCA activity by overexpression of hepatic stimulator substance gene prevents hepatic cells from ER stress-induced apoptosis. | 2013 | Details |
A22879 | 24259612 | Ann Pharmacother | Resistant nonalcoholic fatty liver disease amelioration with rosuvastatin and pioglitazone combination therapy in a patient with metabolic syndrome. | 2013 | Details |
A22982 | 24138963 | Mayo Clin Proc | Association of coronary artery calcification with hepatic steatosis in asymptomatic individuals. | 2013 | Details |
A23042 | 24083161 | Indian J Endocrinol Metab | Emerging risk factors for cardiovascular diseases: Indian context. | 2013 | Details |
A23072 | 24065998 | Hepat Mon | Dietary Quality Indices and Biochemical Parameters Among Patients With Non Alcoholic Fatty Liver Disease (NAFLD). | 2013 | Details |
A23083 | 24055888 | Biochim Biophys Acta | tert-Butylhydroquinone (tBHQ) protects hepatocytes against lipotoxicity via inducing autophagy independently of Nrf2 activation. | 2013 | Details |
A23098 | 24041461 | Mitochondrion | Berberine reverts hepatic mitochondrial dysfunction in high-fat fed rats: a possible role for SirT3 activation. | 2013 | Details |
A23211 | 23958268 | Atherosclerosis | Independent associations of low 25 hydroxy vitamin D and high parathyroid hormonal levels with nonalcoholic fatty liver disease in Asian Indians residing in north India. | 2013 | Details |
A23401 | 23812039 | Am J Physiol Gastrointest Liver Physiol | Genome-wide transcriptome analysis identifies novel gene signatures implicated in human chronic liver disease. | 2013 | Details |
A23455 | 23763294 | Alcohol Clin Exp Res | Genetic resistance to liver fibrosis on A/J mouse chromosome 17. | 2013 | Details |
A23466 | 23755269 | PLoS One | Lepr(db/db) Mice with senescence marker protein-30 knockout (Lepr(db/db)Smp30(Y/-)) exhibit increases in small dense-LDL and severe fatty liver despite being fed a standard diet. | 2013 | Details |
A23476 | 23745619 | Metab Syndr Relat Disord | Nonalcoholic fatty liver disease and reduced serum vitamin D(3) levels. | 2013 | Details |
A23611 | 23627007 | Crit Rev Immunol | Role of scavenger receptors in the pathophysiology of chronic liver diseases. | 2013 | Details |
A23764 | 23504808 | Hepatology | Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association? | 2013 | Details |
A23802 | 23465592 | J Nutr Biochem | S-allyl cysteine attenuates free fatty acid-induced lipogenesis in human HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway. | 2013 | Details |
A23812 | 23453039 | Metabolism | Involvement of regucalcin in lipid metabolism and diabetes. | 2013 | Details |
A23838 | 23435355 | Biochem Pharmacol | Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway. | 2013 | Details |
A23863 | 23420151 | Clinics (Sao Paulo) | Dietary patterns in Brazilian patients with nonalcoholic fatty liver disease: a cross-sectional study. | 2013 | Details |
A23874 | 23411507 | Endocr J | High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome. | 2013 | Details |
A24025 | 23295058 | Liver Int | Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats. | 2013 | Details |
A24304 | 23023705 | J Clin Invest | Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. | 2012 | Details |
A24385 | 22950627 | Scand J Clin Lab Invest | A novel appetite peptide, nesfatin-1 in patients with non-alcoholic fatty liver disease. | 2012 | Details |
A24487 | 22846353 | Clin Calcium | [Magnesium and liver]. | 2012 | Details |
A24500 | 22829522 | Diabetes Care | Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people. | 2012 | Details |
A24666 | 22634121 | J Hepatol | D-livering the message: the importance of vitamin D status in chronic liver disease. | 2012 | Details |
A24864 | 22420611 | Clin Sci (Lond) | Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet. | 2012 | Details |
A25003 | 22254139 | Radiol Res Pract | The severity of Fatty liver disease relating to metabolic abnormalities independently predicts coronary calcification. | 2011 | Details |
A25043 | 22221411 | Lipids Health Dis | Palmitic and linoleic acids induce ER stress and apoptosis in hepatoma cells. | 2012 | Details |